Table 1.

Demographic, clinical and laboratory features in patients with sarcoidosis.

Features	Patients, N = 42
Age, mean (years)	45.2
Disease duration, mean (years)	3.5
Sex (women/men)	32/10
Erythema nodosum	20 (47.6%)
Uveitis	3 (7.1%)
Myositis	1 (2.3%)
Neurosarcoidosis	1 (2.3%)
Arthritis	32 (76.2%)
Elevated serum ACE level	15 (35.7%)
ANA positivity	12 (28.5%)
RF positivity	7 (16.6%)
Stage 1	12 (28.5%)
Stage 2	22 (52.4%)
Stage3/4	4/4 (9.5%)

ACE, angiotensin-converting enzyme; ANA, antinuclear antibody; RF, rheumatoid factor.